Synthesis of doxorubicin–peptide conjugate with multidrug resistant tumor cell killing activity
- 15 September 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (22), 5071-5075
- https://doi.org/10.1016/j.bmcl.2005.07.087
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Intracellular targeting of polymer-bound drugs for cancer chemotherapyAdvanced Drug Delivery Reviews, 2005
- Inhibitors of Multidrug Efflux Transporters: Their Membrane and Protein InteractionsMini-Reviews in Medicinal Chemistry, 2005
- Cell-penetrating peptides: mechanism and kinetics of cargo deliveryAdvanced Drug Delivery Reviews, 2005
- Delivery of bioactive molecules into the cell: the Trojan horse approachMolecular and Cellular Neuroscience, 2004
- A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrenceJournal of Pharmacy and Pharmacology, 2004
- Construction and Characterization of aPseudomonas aeruginosaMucoid Exopolysaccharide-Alginate Conjugate VaccineInfection and Immunity, 2003
- Intravenous TAT-GDNF Is Protective After Focal Cerebral Ischemia in MiceStroke, 2003
- Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.Pharmaceutical Research, 2003
- ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugsJournal of Controlled Release, 2001
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999